MILAN — At first, the world’s top pairs skaters appeared to have cleansed the bad spirits of a men’s competition that ended so sloppily some could only conjure the excuse of a Friday the 13th curse.

Feb. 10 (UPI) --The United States' Ilia Malinin delivered a near-perfect short program Tuesday night in Milano, putting the two-time world champion firmly atop the men's singles standings heading into ...

Blue Origin has “paused” its New Shepard program for the next two years, a move that likely signals a permanent end to the suborbital space tourism initiative. The small rocket and capsule have been ...

In a Jan. 16 news release, the Kennedy Center announced that Kevin Couch would be its new senior vice president of artistic programming. On Jan. 22, the center posted the announcement on X. Not a week ...

Kevin Couch, a veteran live entertainment exec and musician, was announced as the head of artistic programming at the newly rechristened Trump Kennedy Center on Jan. 16. Less than two weeks later, ...

Kevin Couch, who was announced as senior vice president of artistic programming less than two weeks ago, is the latest to leave since President Trump took control of the center last year. By Ashley ...

The Kennedy Center‘s head of artistic programming has resigned, less than two weeks since his hire was announced. Kevin Couch told The Washington Post and The New York Times that he had stepped down ...

With one month until DCC XVI, the Dolphins Cancer Challenge (DCC) announced Grammy Award-winning rock band, Blues Traveler, as the headliner for the Finish Line Celebration at its signature ride, ...

Programming is the backbone of modern technology, and understanding a programming languages list is essential for developers, students, and tech enthusiasts. In 2026, Python leads AI and data science ...

Two new shows will debut this weekend on PBS following the end of the long-running "PBS News Weekend" program, which aired its last episode earlier this month due to a loss of federal funding. The ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...